News
Former Brazilian President Jair Bolsonaro denies accusations of attempting to stage a coup following his loss in the 2022 election.
The U.S.-listed shares of Danish drugmaker Novo Nordisk rose Tuesday following a report that an activist investor is building a stake in the Ozempic maker.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Novo Nordisk (NVO) have what it takes? Let's find out.
Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual agreement." ...
The Chargers will face the Chiefs in São Paulo, Brazil, in a 2025 Week 1 NFL matchup. Here's how to get tickets for the game with pricing and team schedules.
Novo Nordisk has agreed a partnership worth up to $2.2bn with US biotech Septerna, as the Danish drugmaker tries to shore up its pipeline of potential next-generation obesity drugs.
2025 NFL schedule leak rumors: Chiefs could travel to São Paulo for historic Week 1 clash with division rival (image credit: getty) ...
Eli Lilly looks set to steal Novo Nordisk’s weight-loss crown Despite a late start, the American firm is bearing down on its Danish rival ...
Sports Mole previews Tuesday's Copa Libertadores clash between Alianza Lima and Sao Paulo, including predictions, team news and possible lineups.
Meanwhile, Novo Nordisk has been working to innovate its semaglutide treatments. It recently came to light that the company is developing an oral form of Ozempic, Wegovy's sibling medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results